• Latest Posts

UniQure’s cure for rare Lysosomal disease ready for phase III trial

German Viral Vector Producer SIRION pursues its American dream and opens in Boston

GSK sparks off the Gene Therapy resurgence

Live from Bio-Europe 2015: The product development challenges in the gene therapy field

Forbion Capital Partners: a Leading European Biotech VC is rising!